@KnowYourPulse @BHRSociety

Prof John Camm gives an expert assessment of the new EHRA document on use of antiarrhythmic drugs & still the mainstay of treatment for the majority of our patients. #las2026

The great debate at #las2026 - left atrial appendage closure: expanding evidence or expanding enthusiasm? A winning argument by @drjohnm and a very balanced and considered rebuttal by Tim Betts. More agreement than disagreement! @ShouvikHaldar @MillbrookMed

Excellent review of #AI in electrophysiology by @g_andre_ng today at #LAS2026 . A stimulating presentation!

Catching up with friends (and ex Glasgow EP trainees) @drashnisbet and @g_andre_ng at #las2026 today. Excellent conference - congratulations to @ShouvikHaldar , @MillbrookMed and all the faculty!

The stage is set. Faculty dinner ahead of #LAS2026 with experts joining us from across the UK, Europe and North America for a day focused on the future of arrhythmia care. Looking forward to a day of great discussions and science! @drjohnm @ProfDConnelly @JohnSilberbauer @g_andre_ng @DavideFabb amongst many others!

London Arrhythmia Summit, 12th June. Come join us!! ...among other interesting topics in EP, we will be debating whether PFA is the answer for VT ablation, is it?? 🤔 ➡️Registration link: millbrook-events.co.uk/event… #EPeeps

📌Transseptal puncture in cardiovascular interventions: a clinical consensus statement of the European Heart Rhythm Association, the Heart Failure Association, the European Association of Percutaneous Cardiovascular Interventions, the European Association of Cardiovascular Imaging of the ESC, and the Association for European Paediatric and Congenital Cardiology 👉ow.ly/tG3450Z9cPt @EuropaceEiC @GiulioConteMD @Dominik_Linz @FraSantoroMD @AndyZhangMD @marcovitoloMD @DavideMei93 #Europace #arrhyhtmias

"LAS was created to be the meeting we would want to attend ourselves" — Dr Shouvik Haldar, Course Director 3 days to go. Registration closes Thursday noon. Friday 12 June · London · Under £100. londonarrhythmiasummit.com/

This has to be the best cryptic crossword clue ever - in today's @guardian !

Sir William Osler, 1849-1919, renowned as the father of modern medicine, famously instructed medical students to: "Listen to your patient, he is telling you the diagnosis." It's a simple dictum, but the foundation of the way Osler revolutionised healthcare by insisting that doctors step away from their desks and focus on their patients. Everyone longs for functioning, joined-up NHS IT, @jamesmurray_ldn (though not via Palantir) - but to suggest, as you have in this post, that history-taking is a tedious irrelevance is to completely misunderstand the nature of medicine. That first conversation between doctor and patient is a close, shrewd, vital therapeutic encounter. As we listen, we observe, appraise, distil. Invariably, the diagnosis can be made. But history-taking, like the rest of medicine, is the marriage of science with humanity. It treats patients as people, not as objects with disease. Through your time, care and attentiveness in history-taking, you communicate something vital to a patient - that they matter and that you care. Please never forget that healthcare is not a production line of objects, it's an enterprise built on relationships, with humanity at its core. Medical history-taking is its bedrock.

Encouraging all NHS Trusts to participate in the PROFID-EHRA randomised clinical trial testing the effectiveness of primary prevention ICD after #heartattack in severe #heartfailure on optimised pharmacotherapies. Contact me if you would like to join.

Is AI replacing EP thinking in mapping and ablation? Session 5 at LAS tackles the question directly. Prof. André Ng, Prof. Paul Friedman & Prof. Sana Al-Khatib on where the technology is actually going — and what it means for how you practice. londonarrhythmiasummit.com/

LAS 2026 approved for 6 CPD credits! Join us for a focused, one-day update in arrhythmia and pacing featuring: ✔️ Practical clinical decision-making ✔️ Expert debate ✔️ Interactive discussion ✔️ Short, high-yield talks Register: londonarrhythmiasummit.com/

This is an excellent thread 🧵 on the comparative effects of warfarin and DOACs on coagulation factors, and the reasons that warfarin is more effective than DOACs in preventing thrombus on mechanical valves...

Atrial fibrillation recurrence and outcomes in patients with hypertrophic cardiomyopathy: Insights from a nationwide real-world cohort @AmroAglanMD @WMCHealth @EthanRowin @LaheyHospital heartrhythmjournal.com/artic…

Do not miss out! If you work in EP, this is the room you want to be in on Friday 12 June. 🌍 World-class faculty 🔥 Unfiltered debates 📊 Practice-changing data No fluff. No safe opinions. ⚡ #LAS2026 👉 londonarrhythmiasummit.com @SanaAlkhatib9 @Mel_Gunawardene @ProfDConnelly @g_andre_ng @JohnWhitaker20 @DavideFabb @DocWajidHussain @drjohnm #LAS2026 👉 londonarrhythmiasummit.com

📅 SAVE THE DATE – #BHRSymposium 2026 A full day of arrhythmia-focused debate, discussion & interactive scenarios where your input shapes the conversation. 📍 Royal College of Physicians, London 🗓️ 5 Nov 2026 More details soon 👀

Great news for MVLS 🎉 The University of Glasgow has once again performed strongly in the latest QS World University Rankings by Subject. We’re particularly proud to see Life Sciences and Medicine ranked in the global top 50, and Anatomy and Physiology in the global top 20

🌍 New insights in cardiac resynchronisation therapy for adults with a systemic right ventricle 💡🫀 A new international multicentre study has just been published, exploring the impact of cardiac resynchronisation therapy (CRT) in adults with a systemic right ventricle (sRV) — a growing and uniquely complex patient population. 📄 Fusco et al., Heart (2025) 🔬 What makes this study remarkable? This is the largest cohort ever reported, including patients with ccTGA and d-TGA after atrial switch. Thanks to a robust propensity-matched analysis, it provides the strongest real-world evidence to date on CRT in this challenging anatomy. 📉 Key findings Despite expectations and past small-scale studies, CRT did not improve survival or event-free survival in adults with an sRV. Even after adjusting for confounders, CRT remained associated with worse outcomes, likely reflecting advanced disease stage and suboptimal timing at the moment of implantation. Moreover, only a minority of patients achieved significant QRS narrowing—highlighting how challenging true resynchronisation can be in this substrate. ⚙️ Why does this matter? Patients with an sRV face increasing rates of heart failure as they age. Understanding which therapies truly work — and which need refinement — is essential to guide future care. This study underscores the need for: ➡️ Better patient selection ➡️ Earlier identification of candidates ➡️ Optimised pacing strategies adapted to sRV physiology ➡️ Exploration of conduction system pacing (CSP) as a more physiological alternative 🔌✨ 🚀 Looking ahead While CRT, as currently applied, may not deliver meaningful benefit in this population, the field is moving fast. Advances in CSP and refined timing may soon reshape how we approach electrical therapy in adults with congenital heart disease. 🔗 A milestone paper that pushes the field forward and reminds us how essential tailored, anatomy-specific strategies are in ACHD. #Cardiology #ACHD #SystemicRV #CRT #HeartFailure #CongenitalHeartDisease #Innovation #Research doi.org/10.1136/heartjnl-202…

Trainees — this one’s for you 🎟 £1 BHRS places 🎟 50% off BJCA trainees 🎟 Early bird rates One day. Real-world arrhythmia & pacing. Limited places — first come, first served londonarrhythmiasummit.com/